Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIO-11006 in Advanced Non-Small Cell Lung Cancer
NCT03472053Phase 2Completed
- Sponsor
- BioMarck Pharmaceuticals, Ltd.
- Start
- Feb 2018
- Primary completion
- Dec 2019
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BIO-11006 in non-small cell lung cancer (NSCLC), sponsored by BioMarck Pharmaceuticals, Ltd.. Started Feb 2018; status: completed.
02
Drugs
BIO-11006
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03472053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03472053.